Lindab expands its current operations in Switzerland with the acquisition of Tecnovent. With the acquisition, Lindab will get access to sales and production of ventilation grilles, roof hoods and rectangular ventilation ducts. Tecnovent has a
Tags :Pestalozzi
Banco Comercial Português (“BCP”) entered into a share purchase and sale agreement with Union Bancaire Privee (“UBP”), pursuant to which UBP agreed to purchase all the shares in Banque Privee BCP (SUISSE). Following receipt
Stellantis has entered into an agreement to sell FCA Switzerland to Bergé Auto. The latter will be taking over responsibility for importing the Abarth, Fiat, Alfa Romeo, Jeep and Fiat Professional brands into Switzerland. The
Ten23 health, a pure-play, patient-centric and sustainable biologics drug product contract development and manufacturing organisation (“CDMO”), backed by 3i Group, has acquired all shares in swissfillon, an FDA and Swissmedic approved drug product-focused CDMO active
Helix Acquisition Corp, a Nasdaq-listed special purpose acquisition company and MoonLake Immunotherapeutics, a Swiss based clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases agreed on a business combination. At
Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialisation of innovative medicines for rare neuromuscular neuromuscular and pulmonary diseases with high unmet medical need, has announced an equity financing of CHF 20
Pestalozzi advises global institutional investors (“Investors”) in connection with an amendment to the up to $44,000,000 equity linked investment in WISeKey International Holding (“WISeKey”) listed at SIX Swiss Exchange and with ADS traded at NASDAQ, agreed
La Mobilière, TX Group, Ringier and General Atlantic form a joint venture to create a digital marketplace group. The CEO of the joint venture will be Gilles Despas, currently CEO of the Scout24 Switzerland
H.C. Wainwright acted as sole placement agent in connection to the private placement of 71,428,572 shares in Relief Therapeutics Holding, a Swiss biopharmaceutical company listed at SIX Swiss Exchange, at a price of CHF 0.21 per
The shareholders of Montana Capital Partners, a European-based private equity secondaries asset manager, have entered into a share purchase agreement regarding the sale of all shares to PGIM, a global investment management business of Prudential
